CTX310, a one-time CRISPR-Cas9 gene-editing therapy, has safely reduced LDL cholesterol and triglycerides in adult patients with difficult-to-treat
Presented at the

CTX310, a one-time CRISPR-Cas9 gene-editing therapy, has safely reduced LDL cholesterol and triglycerides in adult patients with difficult-to-treat
Presented at the

Four major studies presented at AHA 2025 are reshaping strategies for managing atrial fibrillation (AFib) in complex clinical scenarios. OCEAN addresses whether ongoing anticoagulation is necessary after successful catheter ablation, offering…

“When you compare it to side effects of chronic systemic steroid use, Cushing’s syndrome, hyperglycemia, diabetes, hypertension, osteoporosis, osteonecrosis, you name it, those side effects pale in comparison,” Maloney said. “Also, when…

Findings from a small-scale study of adults from families with a genetic connection to frontotemporal dementia (FTD) revealed several benefits to genetic counseling and its effects on empowering those uncertain of diagnosis. Although the study…

In one of his reels, PCOS mentor Drew Baird highlighted a list of everyday foods that might help women struggling with facial hair caused by polycystic ovary syndrome (PCOS). “If you’re struggling with facial hair because of your PCOS,”…

Research Highlights: